Skip to content

Multicenter cohort study on late complications of Langerhans cell histiocytosis patients

Multicenter cohort study on late complications of Langerhans cell histiocytosis patients - Observational study on late complication of LCH

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030023
Enrollment
300
Registered
2017-11-20
Start date
2016-03-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Langerhans cell histiocytosis

Interventions

None listed

Sponsors

Japan LCH Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as LCH between 1996 and 2009, and have been followed up at the facility participating in the Japan LCH Study Group.

Exclusion criteria

Exclusion criteria: 1. Patients who are not proved to have LCH by histological examination 2. Patients who died within 3 years after diagnosis

Design outcomes

Primary

MeasureTime frame
The incidence of late complications over time

Secondary

MeasureTime frame
Risk factors for late complications Evaluation of clinical course of central nervous degenerative LCH

Countries

Japan

Contacts

Public ContactAkira Morimoto

Jichi Medical University Pediatrics

info@jlsg.jp0285-58-7366

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026